欧洲癌症研究与治疗组织（EORTC）-1843研究中SPECTA Arcagen研究的EURACAN项目里罕见胃肠道癌症的分子图谱分析与精准医学：欧洲接受匹配治疗的患者太少。 - Suppr

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.

作者信息

Lamarca A, Morfouace M, Tejpar S, Oliveira J, Capela A, Penel N, Gennigens C, Brasiuniene B, Peron J, Stevovic A, Blay J-Y, Klümpen H-J

机构信息

Department of Oncology-OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid Spain; Department of Medical Oncology, The Christie NHS Foundation, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK.

European Organisation for Research and Treatment of Cancer, Brussels, Belgium.

出版信息

Ann Oncol. 2022 Nov;33(11):1200-1202. doi: 10.1016/j.annonc.2022.07.006. Epub 2022 Aug 1.

DOI:10.1016/j.annonc.2022.07.006

PMID:35926814

Abstract

摘要

相似文献

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.

Ann Oncol. 2022 Nov;33(11):1200-1202. doi: 10.1016/j.annonc.2022.07.006. Epub 2022 Aug 1.

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN.

ESMO Open. 2020 Dec;5(6):e001075. doi: 10.1136/esmoopen-2020-001075.

EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe.

Int J Cancer. 2020 Aug 15;147(4):1180-1184. doi: 10.1002/ijc.32651. Epub 2019 Sep 14.

EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.

NPJ Precis Oncol. 2024 Feb 16;8(1):37. doi: 10.1038/s41698-024-00518-9.

Overview of personalized medicine in GI cancers.

J Gastrointest Surg. 2012 Sep;16(9):1641-4. doi: 10.1007/s11605-012-1949-8. Epub 2012 Jun 29.

Ushering in the Era of Precision Medicine.

Oncology (Williston Park). 2020 Aug 12;34(8):314-316. doi: 10.46883/ONC.2020.3408.0314.

[Not Available].

Tidsskr Nor Laegeforen. 2018 Oct 1;138(15). doi: 10.4045/tidsskr.18.0708. Print 2018 Oct 2.

Precision Medicine in Gastrointestinal Pathology.

Arch Pathol Lab Med. 2016 May;140(5):449-60. doi: 10.5858/arpa.2015-0317-RA.

Molecular profiles in foregut oncology.

Cancer Genet. 2016 Dec;209(12):537-553. doi: 10.1016/j.cancergen.2016.09.008. Epub 2016 Oct 29.

Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors.

Int J Mol Sci. 2023 Sep 19;24(18):14283. doi: 10.3390/ijms241814283.

引用本文的文献

Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.

Lancet Reg Health Eur. 2024 Feb 16;39:100861. doi: 10.1016/j.lanepe.2024.100861. eCollection 2024 Apr.

The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment.

Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):457-461. doi: 10.21037/hbsn-23-215. Epub 2023 May 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.

作者信息

Lamarca A, Morfouace M, Tejpar S, Oliveira J, Capela A, Penel N, Gennigens C, Brasiuniene B, Peron J, Stevovic A, Blay J-Y, Klümpen H-J

机构信息

European Organisation for Research and Treatment of Cancer, Brussels, Belgium.

出版信息

Ann Oncol. 2022 Nov;33(11):1200-1202. doi: 10.1016/j.annonc.2022.07.006. Epub 2022 Aug 1.

DOI:10.1016/j.annonc.2022.07.006

PMID:35926814

Abstract

摘要

相似文献

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.

Ann Oncol. 2022 Nov;33(11):1200-1202. doi: 10.1016/j.annonc.2022.07.006. Epub 2022 Aug 1.

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN.

ESMO Open. 2020 Dec;5(6):e001075. doi: 10.1136/esmoopen-2020-001075.

EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe.

Int J Cancer. 2020 Aug 15;147(4):1180-1184. doi: 10.1002/ijc.32651. Epub 2019 Sep 14.

EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.

NPJ Precis Oncol. 2024 Feb 16;8(1):37. doi: 10.1038/s41698-024-00518-9.

Overview of personalized medicine in GI cancers.

J Gastrointest Surg. 2012 Sep;16(9):1641-4. doi: 10.1007/s11605-012-1949-8. Epub 2012 Jun 29.

Ushering in the Era of Precision Medicine.

Oncology (Williston Park). 2020 Aug 12;34(8):314-316. doi: 10.46883/ONC.2020.3408.0314.

[Not Available].

Tidsskr Nor Laegeforen. 2018 Oct 1;138(15). doi: 10.4045/tidsskr.18.0708. Print 2018 Oct 2.

Precision Medicine in Gastrointestinal Pathology.

Arch Pathol Lab Med. 2016 May;140(5):449-60. doi: 10.5858/arpa.2015-0317-RA.

Molecular profiles in foregut oncology.

Cancer Genet. 2016 Dec;209(12):537-553. doi: 10.1016/j.cancergen.2016.09.008. Epub 2016 Oct 29.

Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors.

Int J Mol Sci. 2023 Sep 19;24(18):14283. doi: 10.3390/ijms241814283.

引用本文的文献

Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.

Lancet Reg Health Eur. 2024 Feb 16;39:100861. doi: 10.1016/j.lanepe.2024.100861. eCollection 2024 Apr.

The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment.

Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):457-461. doi: 10.21037/hbsn-23-215. Epub 2023 May 22.

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.

作者信息

机构信息

出版信息

相似文献

引用本文的文献